Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report

Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report. Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of primary progressive and relapsing multiple sclerosis (MS). Although cases of organizing pneumonia have been reported in associa...

Full description

Saved in:
Bibliographic Details
Published in:Tüberküloz ve toraks 2023-03, Vol.71 (1), p.107-111
Main Authors: Aysan, Nurten, Köybaşı, Gizem, Satıcı, Celal, Demirkol, Mustafa Asım, Arpınar Yiğitbaş, Burcu, Arpaçağ Koşar, Ayşe Filiz
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report. Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of primary progressive and relapsing multiple sclerosis (MS). Although cases of organizing pneumonia have been reported in association with other antiCD20 agents such as rituximab, there is insufficient data in the literature on Ocrelizumab-associated lung involvement. Herein, we present a case of organizing pneumonia in a 37-year-old female patient with multiple sclerosis following Ocrelizumab use.
ISSN:0494-1373
2980-3187
DOI:10.5578/tt.20239913